Compare Humana Inc (HUM) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Humana Inc trades at $404.34 (market cap $47.81B), while State Street SPDR S&P Biotech ETF trades at $154.49. The key difference: Humana Inc pays a 0.89% dividend while State Street SPDR S&P Biotech ETF pays none, and Humana Inc is trading nearer its 52-week high, State Street SPDR S&P Biotech ETF nearer its low. Which is the better fit depends on your goals.
| HUM | XBI | |
|---|---|---|
Market Cap | $47.81B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $409.42 | $164.28 |
52-Week Low | $163.67 | $85.16 |
Enterprise Value | $56.85B | — |
Dividend Yield | 0.89% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
